The UK is an attractive place to conduct life science research and development (R&D). However, we must caveat this statement with the words, ‘for now’. 6 September 2023
Across the globe, tense relationships between countries are on the rise. The PwC 25th Annual Global CEO Survey showed that 32% of executives cited geopolitical 17 August 2023
Obesity is one of the most urgent health challenges of our time.With more than half the global population estimated to be either overweight or living with obesi 24 July 2023
Developing new drugs is a complex and expensive process with a high failure rate. In fact, only about one out of 250 preclinical compounds make it to FDA approv 4 July 2023
With evolving patient pathways, advances in technology and surges of new data, traditional commercial models have been disrupted, and the expectations and prefe 9 June 2023
The life sciences industry has always been subjected to transparency requirements. To help avoid compliance violations that may lead to penalties, many life sci 10 May 2023
There have been huge changes in the way highly regulated markets operate in recent years – caused by new regulations.technologies and demands.Manufacturers and 6 April 2023
It seems every other day we hear of a new cyberattack in the news and it’s clear that these attacks are becoming an ever-growing, global concern. 27 March 2023
Róbert Wessman, founder and chairman of Icelandic biosimilars company Alvotech and investment fund Aztiq, offers his vision for affordable global healthcare in 7 February 2023
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.